‌

US Patent 9540433 Human antibodies and antibody-drug conjugates against CD74

Patent 9540433 was granted and assigned to Genmab A/S on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Marije Overdijk0

Sandra Verploegen0

Steen Lisby0

Willem Karel Bleeker0

Patrick Van Berkel0

Paul Parren0

Riemke Van Dijkhuizen0

Date of Patent

January 10, 2017

Patent Application Number

13982959

Date Filed

February 1, 2012

Patent Citations Received

US Patent 12077790 Optimized binuclease fusions and methods

0

US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof

0

Patent Primary Examiner

Patent abstract

Isolated human monoclonal antibodies which bind to human CD74 and related antibody-drug conjugates are disclosed. Pharmaceutical compositions comprising the antibodies or antibody-drug conjugates, and therapeutic and diagnostic methods for using the antibodies and/or antibody-drug conjugates, are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9540433 Human antibodies and antibody-drug conjugates against CD74

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.